<DOC>
	<DOCNO>NCT03009721</DOCNO>
	<brief_summary>The purpose study investigate effectiveness safety Olostar Tab patient essential hypertension dyslipidemia</brief_summary>
	<brief_title>Observational Study Investigate Effectiveness Safety Olostar Tab Patients With Essential Hypertension Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Male female â‰¥ 19 Patients record blood pressure ( SBP/DBP ) LDLC prescription Olostar Tab . Patients participate clinical trial PMS Olostar Tab .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>